rocki
mountain
virolog
associ
establish
address
critic
need
venu
showcas
region
scientist
investig
facet
interact
order
provid
environ
graduat
student
could
interact
establish
virologist
new
investig
could
establish
product
collabor
colorado
state
univers
mountain
campu
locat
mile
west
fort
collin
colorado
select
venu
sinc
locat
base
continent
divid
provid
suffici
seclus
enhanc
attend
present
program
free
time
provid
explor
beauti
mountain
set
year
meet
grown
includ
signific
contribut
prion
biologist
mani
nation
intern
speaker
meet
grown
past
region
focu
nonetheless
annual
rmva
meet
maintain
uniqu
abil
provid
forum
advanc
scienc
mentorship
profession
childcar
provid
facilit
attend
individu
young
children
poster
session
kid
preform
kidtagion
skit
portray
pathogen
transmiss
fomit
product
obtain
glow
review
keynot
speaker
dr
w
ian
lipkin
aka
viru
hunter
also
chief
scientif
advisor
film
contagion
taken
togeth
annual
rocki
mountain
virolog
associ
meet
figur
continu
legaci
virolog
prion
biolog
mentorship
altitud
ft
km
clear
night
sky
easi
see
star
podium
figur
select
abstract
present
rebecca
broeckel
along
emili
fitzmey
sonja
best
rocki
mountain
laboratori
niaid
nih
hamilton
mt
usa
investig
restrict
tickborn
flavivirus
tripartit
motif
contain
protein
tickborn
mosquitoborn
flavivirus
tbfv
mbfv
caus
fatal
hemorrhag
fever
neurolog
diseas
human
type
interferon
ifn
critic
host
resist
flavivirus
mechan
action
potenti
specif
recognit
differ
flaviviru
speci
fulli
understood
tripartit
motif
contain
protein
ifnstimul
gene
origin
identifi
major
restrict
factor
rhesu
macaqu
group
recent
discov
human
nonhuman
primat
significantli
impair
replic
tbfv
mbfv
howev
precis
flaviviru
molecular
target
known
determin
mechan
restrict
sensit
tbfv
call
langat
viru
lgtv
passag
cell
stabli
overexpress
resist
occur
two
independ
viral
passag
result
mutat
valin
nonstructur
protein
viral
proteasehelicas
recombin
lgtv
bear
mutat
resist
restrict
recombin
wild
type
lgtv
remain
sensit
show
use
electron
microscopi
apextag
recruit
er
surround
site
lgtv
replic
complex
importantli
recombin
lgtv
resist
mutat
recruit
replic
complex
demonstr
requir
recognit
work
uncov
mechan
specif
ifn
respons
recognit
disrupt
flaviviru
replic
complex
inform
gain
use
determin
whether
escap
mbfv
requir
infect
pathogenesi
human
anim
human
studi
perform
abhilash
chiramel
rocki
mountain
lab
nih
hamilton
mt
usa
investig
role
protein
famili
sequenc
similar
member
b
transcript
variant
flaviviru
replic
endoplasm
reticulum
er
form
multipart
network
continu
sheet
tubul
extend
nuclear
envelop
plasma
membran
erresid
protein
serv
key
receptor
lysosom
degrad
er
term
erphagi
deplet
lead
er
expans
overexpress
result
er
fragment
autolysosom
degrad
therebi
control
er
morpholog
sinc
flaviviru
replic
occur
er
membran
investig
impact
erphagi
zika
viru
zikv
west
nile
viru
wnv
dengu
viru
denv
infect
mous
embryon
fibroblast
flavivirus
render
cell
highli
permiss
viru
replic
found
flavivirus
util
viral
proteas
cleav
human
mous
potenti
facilit
er
expans
viru
replic
importantli
could
confirm
cleavag
endogen
human
upon
denv
infect
lastli
determin
role
erphagi
flaviviru
pathogenesi
mice
defici
infect
zikv
deplet
cell
cultur
support
higher
level
flaviviru
replic
mice
suscept
zikv
infect
compar
wildtyp
mice
data
suggest
erexpans
induc
flavivirus
cleavag
may
occur
local
facilit
optim
replic
howev
loss
augment
viru
replic
vivo
gener
involv
modul
host
immun
result
identifi
cellular
target
flaviviru
antagon
promot
replic
suggest
addit
erphagi
receptor
eg
examin
fulli
elucid
antivir
potenti
erphagi
anim
experi
perform
per
approv
protocol
rml
anim
care
use
committe
acuc
kelli
du
pont
depart
chemistri
colorado
state
univers
fort
collin
co
usa
present
work
investig
role
motif
v
flaviviru
nonstructur
protein
unwind
doublestrand
rna
intermedi
critic
replic
packag
flaviviru
rna
genom
unwind
flaviviru
dsrna
achiev
ctermin
helicas
domain
known
transloc
along
unwind
dsrna
atpdepend
manner
howev
mechan
energi
transduct
atp
rna
bind
pocket
well
understood
understand
energi
travel
helicas
target
specif
area
helicas
antivir
develop
previou
molecular
dynam
md
simul
publish
group
identifi
conserv
motif
v
potenti
commun
hub
energi
transduct
pathway
investig
role
motif
v
use
combin
studi
molecular
dynam
biochemistri
virolog
clarifi
energi
atp
hydrolysi
use
drive
helicas
activ
wildtyp
sever
mutant
identifi
test
sever
biochem
assay
viral
replic
assay
analyz
md
simul
observ
possess
hyperact
helicas
phenotyp
mean
mutat
caus
helicas
unwind
dsrna
quickli
wild
type
wt
interestingli
flaviviru
replicon
mutat
demonstr
reduc
viral
replic
compar
wt
suggest
hyperact
helicas
function
detriment
viral
genom
replic
overal
data
help
defin
linkag
atp
hydrolysi
helicas
activ
within
conserv
motif
v
provid
valuabl
new
insight
biophys
mechan
atpas
driven
helicas
function
human
anim
studi
perform
alison
gilchrist
depart
molecular
cellular
development
biolog
biofronti
institut
univers
colorado
boulder
boulder
co
usa
investig
diacylglycerol
oacyltransferas
host
protein
cleav
dengu
viru
infect
dengu
viru
mosquitoborn
pathogen
highli
preval
tropic
region
world
pois
becom
import
human
health
temper
region
global
warm
produc
warmer
wetter
climat
dengu
viru
genom
encod
proteas
known
cleav
least
one
host
protein
well
viral
polypeptid
use
machin
learn
predict
new
host
target
dengu
viru
proteas
order
find
undiscov
interact
dengu
viru
infect
identifi
host
protein
recogn
cleav
dengu
viru
proteas
also
identifi
cleavag
motif
show
cleavag
motif
mutat
dengu
proteas
incap
cleav
predict
dengu
viru
manipul
host
lipid
environ
prevent
product
triacylglycerol
diacylglycerol
process
facilit
human
anim
studi
perform
charl
grose
univers
iowa
iowa
citi
ia
usa
discuss
inhibit
varicellazost
viru
vzv
assembl
three
diverg
inhibitor
autophagi
publish
paper
laboratori
shown
vzv
induc
autophagi
infect
cell
increas
far
level
basal
autophagi
autophagi
inhibit
vzv
titer
markedli
reduc
second
autophagi
inhibit
autophagi
relat
sirna
vzv
titer
reduc
third
studi
select
antiautophagi
antibiot
bafilomycin
baf
baf
inhibitor
vacuolartyp
h
atpas
baf
impair
autophag
flux
acid
vesicl
postul
baf
would
also
decreas
vzv
assembl
infect
baf
ad
infect
monolay
midway
infecti
cycl
declin
vzv
titer
studi
confoc
microscopi
defin
site
block
inconclus
howev
studi
transmiss
electron
microscopi
strike
treatment
baf
numer
nake
capsid
seen
nucleu
cytoplasm
howev
envelop
particl
seen
cytoplasm
vacuol
associ
exocytosi
virion
seen
plasma
membran
review
archiv
micrograph
control
infect
unabl
find
similar
exampl
short
baf
specif
block
secondari
envelop
capsid
within
vzv
assembl
complex
cytoplasm
anim
human
studi
perform
elena
lian
arthropodborn
infecti
diseas
laboratori
depart
microbiolog
immunolog
patholog
colorado
state
univers
fort
collin
co
usa
investig
noncanon
role
arachidon
acid
proinflammatori
precursor
provir
molecul
dengu
infect
dengu
virus
denv
pose
sever
threat
estim
billion
individu
everi
year
better
understand
pathogenesi
virus
critic
determin
host
metabol
pathway
deliber
alter
facilit
viral
infect
oppos
mediat
antivir
respons
one
pathway
alter
upon
infect
arachidon
acid
aa
metabol
pathway
canon
antivir
due
role
inflamm
function
aa
metabol
ambigu
regard
denv
due
dual
role
aa
lipid
metabol
immun
respons
denv
manipul
lipid
metabol
mediat
massiv
expans
endoplasm
reticulum
membran
replic
therefor
aa
polyunsatur
fatti
acid
may
necessari
membran
architectur
requir
support
viral
replic
identifi
aa
upregul
metabol
truli
antivir
denv
type
infect
synthesi
aa
transform
inflammatori
product
inhibit
de
novo
synthesi
aa
block
inhibit
fatti
acid
desaturas
releas
aa
phospholipid
prevent
inhibit
variou
phospholipas
inhibit
block
initi
aa
metabol
inhibit
enzym
decreas
infecti
viral
titer
indic
aarel
lipid
metabol
pathway
critic
replic
therefor
aa
metabol
play
strictli
antivir
role
infect
may
pose
dual
function
human
anim
studi
perform
raina
plowright
montana
state
univers
bozeman
mt
usa
discuss
process
pathogen
spillov
anim
human
requir
seri
event
align
space
time
explor
nonlinear
interact
among
event
drive
rate
spillov
use
batvirus
model
system
track
viru
reservoir
host
popul
environ
human
examin
barrier
must
overcom
allow
crossspeci
transmiss
data
hendra
viru
show
recent
ecolog
chang
determin
spillov
risk
risk
possibl
revers
strateg
ecolog
intervent
human
anim
studi
perform
laura
st
clair
arthropodborn
infecti
diseas
laboratori
depart
microbiolog
immunolog
patholog
colorado
state
univers
fort
collin
co
usa
discuss
relationship
flaviviru
infect
sphingolipid
metabol
sphingolipid
long
recogn
role
cellular
membran
structur
integr
howev
sphingolipid
recent
emerg
potent
bioactiv
molecul
mediat
sever
cellsign
pathway
includ
host
immun
respons
pathogenes
diseas
insulinresist
diabet
alzheim
cancer
viral
infect
link
perturb
sphingolipid
homeostasi
other
previous
shown
dengu
virus
denv
significantli
alter
sphingolipid
metabol
human
mosquito
cell
human
sera
infect
patient
inhibit
sphingolipid
desaturas
deg
involv
final
step
de
novo
ceramid
synthesi
shown
significantli
reduc
viral
genom
replic
infecti
particl
releas
mosquito
cell
sera
collect
patient
infect
denv
signific
increas
sphingolipid
febril
phase
subsequ
regul
defervesc
convalesc
phase
observ
decreas
serum
denv
also
shown
drive
factor
endotheli
barrier
failur
subsequ
vascular
leakag
observ
sever
dengu
diseas
observ
provid
insight
immunomodulatori
effect
lipid
hypothes
certain
metabolit
sphingolipid
metabol
requir
denv
establish
product
infect
metabolit
alter
host
order
activ
host
antivir
respons
present
preliminari
data
mechan
control
sphingolipid
homeostasi
infect
dengu
zika
virus
shed
light
viru
versu
hostspecif
arm
pathway
influenc
flaviviru
diseas
outcom
human
anim
studi
perform
joel
bain
along
clair
birkenheu
louisiana
state
univers
baton
roug
la
usa
present
data
use
precis
nuclear
run
follow
deep
sequenc
proseq
determin
rna
polymeras
ii
pol
ii
occup
cell
infect
herp
simplex
viru
nucleotid
resolut
within
h
infect
pol
ii
reloc
viral
gene
time
pol
ii
displac
cellular
promot
proxim
paus
ppp
site
bodi
cellular
gene
wherea
viral
infect
increas
pol
ii
occup
mani
gene
involv
cellular
secret
prevent
apoptosi
infect
caus
extens
termin
zone
cellular
gene
effect
correl
low
mrna
accumul
cytoplasm
previou
model
explain
product
differ
viral
gene
differ
time
infect
propos
recruit
pol
ii
differ
tempor
class
herp
simplex
viru
type
gene
differ
time
howev
found
pol
ii
recruit
tempor
class
gene
h
despit
longstand
observ
late
gene
effici
express
time
recruit
late
gene
h
post
infect
increas
strike
differ
immedi
earli
late
gene
earli
time
effici
movement
immedi
earli
gene
bodi
prolong
paus
pol
ii
late
gene
ppp
site
contrast
promot
proxim
paus
becam
promin
immedi
earli
gene
h
post
infect
progress
elong
rapid
late
gene
de
novo
viral
protein
synthesi
necessari
full
pol
ii
occup
immedi
earli
gene
block
dna
replic
acyclovir
phosphonoacet
acid
preclud
full
pol
ii
occup
along
genom
remain
pol
ii
occupi
ppp
site
especi
late
gene
collect
data
suggest
dna
replic
necessari
elong
bodi
late
gene
progress
paus
state
elong
major
previous
underappreci
contributor
regul
hsv
transcript
product
infect
anim
human
studi
perform
clair
h
birkenheu
along
joel
bain
louisiana
state
univers
baton
roug
la
usa
discuss
transcript
gene
regul
cascadelik
fashion
start
express
immedi
earli
ie
gene
end
true
late
gene
use
cytoplasm
rna
sequenc
rnaseq
precis
nuclear
runon
proseq
global
runon
groseq
found
hpi
immedi
earli
gene
transcript
predomin
late
gene
poorli
transcrib
howev
substanti
rna
polymeras
ii
pol
ii
load
observ
gene
tempor
class
hpi
late
gene
cytoplasm
transcript
significantli
increas
reflect
pol
ii
occup
seen
proseq
howev
strike
differ
gene
differ
tempor
class
observ
compar
proseq
data
groseq
data
data
show
pol
ii
complex
accumul
downstream
transcript
start
site
tss
ie
gene
enter
gene
bodi
within
min
contrast
pol
ii
remain
paus
downstream
tss
gene
least
min
data
conclud
tempor
cascad
gene
express
regul
pol
ii
recruit
onto
promot
differ
tempor
class
also
select
pol
ii
complex
elong
appropri
time
human
anim
studi
perform
david
bloom
univers
florida
colleg
medicin
gainesvil
fl
usa
review
role
hsv
noncod
rna
latenc
reactiv
latenc
lytic
gene
express
repress
abund
rna
express
occur
primarili
long
repeat
region
rl
genom
latencyassoci
transcript
lat
transcrib
rl
long
consid
hallmark
latenc
though
becom
clear
subset
neuron
contain
hsv
dna
produc
detect
lat
addit
least
eight
microrna
mirna
recent
addit
long
noncod
rna
lncrna
map
lat
region
number
biolog
phenotyp
map
lat
region
includ
function
facilit
establish
mainten
reactiv
latenc
well
facilit
neuron
surviv
antiapoptosi
central
difficulti
dissect
specif
genet
function
respons
phenotyp
relat
genet
complex
rl
region
tendenc
delet
mutant
alter
multipl
genet
element
talk
describ
recent
result
use
ribozym
target
specif
rna
vivo
use
aav
vector
well
use
vitro
human
neuron
cultur
system
dissect
lat
mirna
function
character
differ
profil
lncrna
express
latenc
anim
studi
perform
follow
guidelin
protocol
approv
institut
anim
care
use
committe
univers
florida
molli
butler
along
nunya
chotiwan
jasmin
donkoh
conni
brewster
sandra
quackenbush
rushika
perera
joel
rovnak
depart
microbiolog
immunolog
patholog
colorado
state
univers
fort
collin
co
usa
share
work
dengu
virus
among
aggress
arthropodborn
diseas
worldwid
virus
induc
metabol
chang
within
infect
cell
upregul
metabol
pathway
necessari
meet
demand
viral
replic
metabol
chang
includ
increas
glucos
metabol
autophagi
ultim
promot
viral
genom
replic
well
infecti
particl
format
matur
mechan
chang
occur
known
least
part
viral
direct
complex
interact
host
viral
nonstructur
protein
interest
transcript
regul
metabol
chang
investig
role
host
transcript
regul
cyclindepend
kinas
dengu
infect
mediat
viral
induc
metabol
chang
show
transcript
regul
select
metabol
gene
express
also
type
interferon
respons
surpris
contradict
demonstr
context
dengu
infect
transcript
regul
provir
antivir
process
show
manipul
activ
chemic
inhibit
express
lentivirusmedi
shrna
knockdown
chang
outcom
dengu
infect
influenc
viral
genom
replic
ultim
infecti
particl
product
therefor
transcript
hub
induc
gene
express
dengu
infect
manipul
alter
cours
viral
infect
human
anim
studi
perform
jasmin
donkoh
along
molli
butler
conni
brewster
rushika
perera
sandra
quackenbush
joel
rovnak
depart
microbiolog
immunolog
patholog
colorado
state
univers
fort
collin
co
usa
share
work
regard
zika
viru
zikv
mosquito
born
flaviviru
associ
outbreak
microcephali
south
america
zikv
link
case
syndrom
fatal
enceph
myeliti
well
neurolog
complic
denv
close
rel
zikv
shown
alter
cellular
metabol
result
alter
metabolit
host
protein
found
zikv
infect
lead
induc
express
host
mediat
complex
protein
cyclin
depend
kinas
promot
viru
replic
transcript
cofactor
regul
gene
express
multipl
metabol
pathway
show
well
glycolyt
enzym
hexokinas
increas
zikv
infect
use
kinas
inhibitor
senexin
demonstr
requir
increas
express
also
show
zikv
genom
rna
particl
decreas
attenu
zikv
replic
may
due
decreas
avail
metabolit
necessari
nucleic
acid
fatti
acid
synthesi
human
anim
studi
perform
sven
heinz
along
loran
texari
michael
gb
hay
max
w
chang
ninvita
givark
christoph
benner
depart
medicin
school
medicin
univers
california
san
diego
la
jolla
ca
usa
lar
pach
infecti
inflammatori
diseas
center
sanford
burnham
prebi
medic
discoveri
institut
la
jolla
ca
usa
matthew
urbanowski
alexand
rialdi
kri
white
randi
albrecht
ivan
marazzi
adolfo
megan
l
shaw
icahn
school
medicin
mount
sinai
new
york
ny
usa
studi
effect
nuclear
replic
influenza
viru
iav
host
genom
structur
found
iav
disrupt
host
genom
interact
downstream
highli
transcrib
gene
effect
caus
iav
nonstructur
protein
inhibit
premrna
cleavag
polyadenyl
signal
result
nuclear
retent
unprocess
newli
transcrib
mrna
transcript
includ
antivir
gene
failur
rna
polymeras
ii
termin
transcript
ensu
readthrough
transcript
past
end
gene
disrupt
cohesinmedi
genom
interact
downstream
decompact
region
frequent
switch
inact
activ
chromatin
compart
studi
uninfect
cell
expos
strong
transcript
stimuli
indic
rna
polymeras
ii
transcript
gener
exert
effect
suggest
mechan
transcript
contribut
shape
chromosom
conform
studi
use
human
tissu
sampl
deem
nonhuman
subject
research
institut
review
board
icahn
school
medicin
mount
sinai
qing
yang
along
sara
sawyer
robin
dowel
depart
molecular
cellular
development
biolog
biofronti
institut
univers
colorado
boulder
co
usa
discuss
potenti
role
mitogenactiv
protein
kinas
mapk
transcript
regul
typei
interferon
respons
typei
interferon
respons
form
front
line
cellautonom
defens
viral
infect
janu
kinas
signal
transduc
activ
transcript
jakstat
signal
cascad
regard
key
initi
express
interferonstimul
gene
isg
underli
transcript
regulatori
network
lack
tempor
contextu
resolut
use
nascent
transcript
analysi
identifi
group
transcript
factor
undergo
rapid
activ
deactiv
cell
undergo
interferon
treatment
cluster
analysi
reveal
mapk
master
regul
transcript
factor
mapk
known
master
switch
nuclear
factor
kappalightchainenhanc
activ
b
cell
mediat
inflammatori
respons
achiev
via
phosphoryl
histon
transcript
activ
phosphoryl
creat
necessari
chromatin
environ
transcript
initi
surprisingli
inhibit
mapk
also
potent
suppress
isg
transcript
even
presenc
interferon
strong
phenotyp
suggest
mapk
like
also
play
essenti
role
potenti
isg
transcript
howev
compet
model
suggest
depend
could
also
result
phosphoryl
nascent
transcript
analysi
context
inhibit
hope
resolv
underli
mechan
add
essenti
transcript
switch
exist
ifn
signal
pathway
anim
human
studi
perform
jayasri
da
sarma
lerner
research
institut
cleveland
clinic
cleveland
oh
usa
indian
institut
scienc
educ
research
kolkata
india
discuss
protect
role
interferoninduc
protein
neurotrop
viru
infect
interferon
ifn
induc
tetratricopeptid
repeat
gene
repres
mice
ifn
induc
tetratricopeptid
repeat
known
benefici
protect
mice
lethal
neurotrop
viru
infect
restrict
viral
replic
amplifi
antivir
respons
use
neurotrop
coronaviru
infect
deplet
mice
report
absenc
viral
replic
dramat
increas
mice
develop
sever
neuropathi
despit
enorm
viral
load
defici
mice
impair
microgli
activ
recruit
peripher
innat
monocyteleukocyt
central
nervou
system
cn
consequ
mice
less
enceph
impli
perivascular
cuf
microgli
nodul
format
homeostat
interact
microglia
cn
resid
neural
cell
well
endotheli
cell
blood
cn
barrier
chemokin
chemokin
receptor
known
acceler
effici
leukocyt
adhes
migrat
cn
may
disrupt
defici
mice
consequ
defici
mice
lack
protect
host
innat
immun
mice
homozyg
mice
background
obtain
breed
coloni
lerner
research
institut
cleveland
clinic
oh
usa
studi
carri
strict
accord
provis
anim
welfar
act
guid
care
use
laboratori
anim
ph
polici
human
care
use
laboratori
anim
anim
experi
perform
complianc
protocol
approv
cleveland
clinic
institut
anim
care
use
committe
ph
assur
number
elizabeth
fortunato
univers
idaho
dept
biolog
scienc
moscow
id
usa
share
work
involv
effect
human
cytomegaloviru
cerebr
organoid
develop
congenit
human
cytomegaloviru
hcmv
infect
caus
broad
spectrum
central
peripher
nervou
system
disord
rang
microcephali
hear
loss
ramif
mandat
studi
interact
neural
cell
neural
progenitor
cell
permiss
lytic
infect
found
primit
induc
pluripot
stem
cell
ipsc
line
suscept
infect
permiss
differenti
infect
ipsc
induc
de
novo
express
viral
antigen
ipsc
cultur
threedimens
gener
cerebr
organoid
close
mimick
vivo
develop
mock
hcmvinfect
ipsc
subject
cerebr
organoid
gener
protocol
hcmv
protein
detect
virusinfect
organoid
day
postinfect
signific
effect
organoid
growth
observ
howev
infect
induc
region
necrosi
larg
vacuol
cyst
similar
describ
manifest
hcmvinduc
birth
defect
infect
dramat
alter
neurolog
develop
organoid
decreas
number
develop
fullyform
cortic
structur
site
associ
chang
architectur
organ
depth
lamin
within
structur
manifest
aberr
express
neural
marker
btubulin
iii
observ
parallel
publish
descript
infect
clinic
sampl
often
possess
spars
antigen
posit
foci
yet
display
area
focal
necrosi
cellular
loss
delay
matur
abnorm
cortic
lamin
parallel
patholog
present
clinic
specimen
highli
tractabl
organoid
system
demonstr
util
system
model
interact
hcmvinduc
birth
defect
human
anim
studi
perform
david
w
hawman
laboratori
virolog
rocki
mountain
laboratori
niaidnih
hamilton
mt
usa
share
work
examin
tcell
respons
mice
crimeancongo
hemorrhag
fever
viru
crimeancongo
hemorrhag
fever
viru
cchfv
tickborn
viru
capabl
caus
sever
diseas
within
infect
human
crimeancongo
hemorrhag
fever
cchf
case
cchf
report
throughout
africa
eastern
europ
middl
east
asia
addit
bite
infect
tick
human
becom
infect
cchfv
anim
husbandri
healthcar
set
care
infect
patient
human
cchf
initi
present
nonspecif
febril
ill
rapidli
progress
hemorrhag
manifest
case
fatal
rate
despit
continu
cchf
case
across
wide
geograph
rang
littl
known
host
adapt
respons
control
infect
investig
host
adapt
immun
respons
cchfv
use
mous
model
recapitul
mani
aspect
sever
acut
diseas
convalesc
seen
human
model
type
interferon
defici
mice
inocul
clinic
isol
cchfv
infect
mice
develop
progress
worsen
clinic
diseas
high
viral
load
elev
inflammatori
cytokin
signific
organ
patholog
recoveri
acut
diseas
coincid
viru
specif
antibodi
activ
tcell
studi
shown
distinct
tcell
respons
cchfv
liver
spleen
two
key
site
viral
replic
lastli
vivo
studi
shown
deplet
either
tcell
result
significantli
reduc
surviv
indic
tcell
necessari
control
acut
cchfv
infect
howev
tcell
deplet
simultan
exacerb
clinic
diseas
partial
amelior
surviv
improv
cumul
data
suggest
although
tcell
requir
effici
control
cchfv
unbalanc
tcell
respons
may
pathogen
ongo
studi
investig
phenotyp
determin
protect
andor
pathogen
role
tcell
cchf
anim
studi
perform
follow
guidelin
protocol
approv
rocki
mountain
laboratori
institut
anim
care
use
committe
juliett
lewi
depart
microbiolog
immunolog
patholog
colorado
state
univers
fort
collin
co
usa
share
work
investig
use
jamaican
fruit
bat
anim
model
studi
henipavirus
nipah
viru
niv
hendra
viru
hev
pteropid
batborn
virus
genu
caus
fatal
enceph
human
livestock
recent
anoth
henipaviru
cedar
viru
cedv
isol
pteropid
bat
nonpathogen
test
anim
model
dispar
pathogen
cedv
rel
yet
fulli
investig
although
one
hypothesi
cedv
lack
v
w
gene
found
niv
hev
potent
interferon
pathway
antagonist
studi
test
suscept
epitheli
cell
jamaican
fruit
bat
artibeu
jamaicensi
virus
also
examin
antivir
gene
express
epitheli
cell
infect
use
qpcr
array
within
two
day
conspicu
cytopath
effect
cpe
present
cultur
inocul
virus
includ
syncytia
format
common
featur
henipaviru
infect
day
three
cell
inocul
niv
hev
exhibit
extens
cpe
less
pronounc
cedpv
inocul
cell
viral
rna
abund
cultur
supernat
increas
studi
express
sever
dozen
antivir
gene
show
half
upregul
respons
cedpv
infect
wherea
nearli
gene
repress
niv
hev
infect
work
first
show
cell
speci
new
world
bat
suscept
henipavirus
cedpv
elicit
robust
antivir
respons
appear
delay
onset
cpe
viral
replic
niv
hev
repress
antivir
respons
caus
substanti
cpe
cell
death
result
suggest
new
world
bat
may
use
anim
model
studi
henipavirus
anim
studi
perform
follow
guidelin
protocol
approv
institut
anim
care
use
committe
colorado
state
univers
maria
nagel
univers
colorado
school
medicin
aurora
co
usa
discuss
possibl
link
varicella
zoster
viru
alzheim
diseas
alzheim
diseas
ad
character
accumul
insolubl
form
amyloid
compris
amylin
plaqu
extracellular
space
vessel
aggreg
microtubul
protein
tau
intracellular
neurofibrillari
tangl
ischemia
neuroinflamm
caus
amyloid
format
sporad
ad
complex
pathogen
propos
trigger
interact
genet
environment
factor
initi
andor
potenti
diseas
among
infecti
agent
could
contribut
ad
varicella
zoster
viru
vzv
strong
candid
similar
ad
vzv
infect
produc
cerebrovascular
diseas
neuroinflamm
longterm
cognit
impair
furthermor
recent
epidemiolog
studi
show
vzv
reactiv
zoster
significantli
increas
dementia
risk
thu
examin
vzv
contribut
ad
progress
product
amyloidogen
peptid
amyloid
cerebrospin
fluid
csf
patient
vzv
vasculopathi
vzvinfect
primari
human
perineuri
cell
brain
vascular
adventiti
fibroblast
compar
stroke
control
vzv
vasculopathi
csf
elev
level
amylin
amyloid
fibril
correl
viral
titer
significantli
reduc
unchang
vzvinfect
cell
vitro
amylin
upregul
provir
function
intracellular
amyloid
found
extracellular
amyloidogen
environ
produc
subsequ
show
vzv
glycoprotein
b
peptid
form
amyloid
fibril
increas
fibril
format
amylin
dosedepend
manner
result
indic
virus
may
contribut
pathogenesi
ad
upregul
cellular
amyloidogen
protein
produc
selfaggreg
viral
peptid
acceler
amyloid
fibril
studi
use
human
subject
tissu
sampl
either
approv
deem
nonhuman
subject
research
institut
review
board
univers
colorado
lisa
k
popp
along
john
west
charl
wood
nebraska
center
virolog
school
biolog
scienc
univers
nebraska
lincoln
ne
usa
investig
antibodydepend
cellular
cytotox
adcc
novel
function
kaposi
sarcomaassoci
herpesviru
kshv
antibodi
kaposi
sarcomaassoci
herpesviru
recogn
etiolog
agent
kaposi
sarcoma
ks
year
howev
littl
known
factor
drive
diseas
progress
prevent
ks
develop
among
asymptomat
infect
associ
ks
hiv
infect
immunosuppress
high
kshv
viral
load
suggest
essenti
role
immun
respons
limit
kshv
pathogenesi
compon
respons
remain
unknown
exampl
cell
respons
kshv
weak
variabl
ks
patient
infect
asymptomat
individu
addit
neutral
antibodi
frequent
detect
individu
ks
find
suggest
nonneutr
antibodi
may
play
role
prevent
ks
develop
one
potenti
mechan
action
nonneutr
antibodi
antibodydepend
cell
cytotox
howev
studi
investig
role
kshv
antibodi
date
develop
valid
assay
detect
adcc
activ
patient
plasma
kshv
infect
cell
preliminari
data
show
adcc
mediat
antibodi
common
among
asymptomat
individu
may
posit
correl
antibodi
titer
work
ongo
determin
adcc
respons
differ
hiv
statu
asymptomat
individu
patient
ks
studi
use
human
subject
tissu
sampl
either
approv
deem
nonhuman
subject
research
institut
review
board
univers
nebraskalincoln
amber
rico
univers
nebraskalincoln
lincoln
ne
usa
present
reductionist
model
studi
vaccinia
govern
vaccinia
poxvirus
orchestr
complex
manipul
signal
transduct
establish
product
infect
vaccinia
form
signal
transduct
axi
recent
discov
follow
adapt
evolut
viru
suppressor
screen
reveal
absenc
catastroph
viral
replic
develop
reductionist
model
signal
transduct
express
absenc
viral
protein
demonstr
express
lentivir
vector
neg
impact
cellular
growth
importantli
simultan
express
separ
lentivir
vector
rescu
cellular
growth
immunofluoresc
analysi
indic
express
alon
result
misloc
compar
infect
cell
wherea
express
result
typic
nuclear
express
addit
express
assay
confirm
coregul
studi
without
overt
cellular
toxic
develop
induc
lentivir
express
system
induc
inhibit
replic
adapt
viru
mutant
without
impact
cellular
growth
togeth
reductionist
model
express
allow
assess
toxic
via
two
readout
inhibit
cellular
growth
viral
repress
ongo
studi
aim
identifi
mechan
action
regard
poisonantidot
activ
collect
result
confirm
signal
transduct
epistat
natur
presenc
defin
requir
express
absenc
viral
protein
suffici
neg
impact
cellular
biolog
reduc
replic
virus
anim
human
studi
perform
michael
j
rudi
along
penni
clark
kenneth
tyler
neurolog
depart
univers
colorado
school
medicin
aurora
co
usa
present
research
enteroviru
emerg
pathogen
caus
biennial
respiratori
diseas
associ
rapidonset
muscleweak
limb
paralysi
children
term
acut
flaccid
myeliti
recent
histor
viral
isol
unit
state
capabl
infect
spinal
cord
motor
neuron
vivo
neuron
cell
vitro
howev
biolog
basi
increas
virul
recent
acquir
abil
contemporari
induc
cn
diseas
unknown
presenc
absenc
envelop
surround
capsid
anim
viru
influenc
stabil
transmiss
immun
recognit
within
cn
picornavirus
includ
consid
nonenvelop
virus
packag
genom
icosahedr
protein
capsid
releas
cell
lysi
recent
shown
sever
picornavirus
releas
cell
nonlyt
fashion
via
extracellular
vesicl
examin
viral
structur
use
ultracentrifug
densiti
gradient
found
addit
expect
nake
viral
peak
also
second
nake
viru
peak
third
viral
peak
consist
envelop
form
viru
densiti
near
treatment
nonion
deterg
prior
centrifug
elimin
membran
peak
drove
infect
nake
viru
peak
addit
electron
microscopi
reveal
membran
contain
conglomer
viral
particl
character
nanoparticl
via
nanosight
reveal
membranebound
viru
particl
approxim
diamet
taken
togeth
data
suggest
exist
previous
undiscov
membranebound
form
anim
human
studi
perform
mario
santiago
depart
medicin
univers
colorado
amc
aurora
co
usa
discuss
work
examin
differ
subtyp
type
interferon
ifni
cytokin
exhibit
potent
antivir
activ
among
sever
ifni
innat
immun
respons
dictat
critic
roadblock
establish
infect
notabl
compris
distinct
subtyp
previous
report
clinicallyapprov
subtyp
significantli
less
potent
inhibit
primari
mucos
cell
compar
antivir
potenc
correl
bind
affin
subunit
ifni
receptor
suggest
quantit
differ
signal
account
differenti
antivir
activ
find
rais
issu
whether
subtyp
qualit
differ
may
driven
evolut
address
controversi
titrat
recombin
subtyp
report
cell
line
harbor
ifn
respons
element
isr
canon
ifn
stimul
gene
link
luciferas
expect
trigger
isreluciferas
cell
line
correl
significantli
bind
affin
indic
assay
measur
quantit
differ
ifnar
signal
domin
subtyp
express
hivexpos
plasmacytoid
dendrit
cell
normal
quantit
differ
incub
purifi
mucos
cell
n
donor
h
correspond
interferom
evalu
rnaseq
differentiallyinduc
gene
set
threshold
rel
mock
qualit
differ
expect
substanti
overlap
interferom
notabl
observ
follow
alter
gene
compar
individu
subtyp
overlap
interferom
subtyp
rang
alter
gene
alter
subtyp
downregul
multipl
gene
upregul
subtyp
test
ingenu
pathway
analys
suggest
process
could
regul
ifni
other
overal
data
provid
strong
evid
distinct
ifni
qualit
differ
could
import
implic
har
cytokin
antivir
control
studi
use
human
subject
tissu
sampl
either
approv
deem
nonhuman
subject
research
institut
review
board
univers
colorado
nicol
r
sexton
along
eric
belli
mark
cole
spangler
rey
murrieta
jame
wegerlucarelli
gregori
ebel
depart
microbiolog
immunolog
patholog
colorado
state
univers
fort
collin
co
usa
investig
composit
zika
viru
infecti
unit
demonstr
singl
cell
infect
like
begin
multipl
genom
zika
viru
zikv
flavivirida
flaviviru
arthropodborn
infect
result
sever
outcom
particularli
fetus
infect
utero
exactli
zikv
transmit
celltocel
mosquitotohuman
unknown
assum
infect
zikv
well
virus
larg
initi
individu
viru
particl
bind
enter
cell
howev
recent
work
demonstr
virus
deliv
multipl
viru
particl
simultan
collect
particl
deliveri
enhanc
infect
zikv
transmit
cyclic
aed
aegypti
mosquito
vertebr
host
includ
human
human
infect
initi
inject
rel
small
initi
inoculum
compris
genet
complex
viru
popul
sinc
mutat
deceas
viru
fit
collect
particl
transmiss
could
benefit
zikv
arthropodborn
diseas
facilit
mainten
genet
complex
adapt
infect
well
mechan
util
barcod
zikv
infect
african
green
monkey
cell
pick
individu
plaqu
sequenc
determin
number
viru
genom
initi
plaqu
found
rang
one
viru
genom
initi
individu
plaqu
averag
result
two
domin
genom
popul
infecti
unit
zikv
separ
mechan
centrifug
larger
infecti
unit
found
reform
remov
overal
data
suggest
zikv
popul
made
varieti
infecti
unit
size
rare
begin
singl
viru
genom
anim
human
studi
perform
hadrian
spark
depart
immunolog
microbiolog
univers
colorado
school
medicin
aurora
co
usa
discuss
manipul
flaviviru
untransl
region
utr
structur
interact
may
use
novel
vaccin
attenu
strategi
similar
mosquitoborn
flavivirus
zika
viru
zikv
encod
two
rna
structur
untransl
region
utr
viral
genom
prevent
degrad
host
exoribonucleas
viral
rnamedi
resist
result
subgenom
flavivir
rna
sfrna
undigest
utr
accumul
infect
host
cell
previou
studi
shown
xrrnadepend
sfrna
product
necessari
replic
pathogen
flavivirus
howev
littl
understood
function
zikv
xrrna
structur
element
sfrna
product
viral
replic
interact
recent
zikv
tertiari
structur
solv
use
predict
novel
interact
within
pseudoknot
essenti
resist
host
activ
singl
cytosin
posit
thought
stabil
phosphat
backbon
kink
form
rna
pseudoknot
base
inform
hypothes
replac
cytosin
guanin
base
posit
either
zika
decreas
product
sfrna
infect
lead
reduc
viral
replic
pathogen
gener
infecti
zikv
clone
mutat
mutat
show
mutant
exhibit
decreas
viral
replic
infect
compar
wild
type
wt
clonederiv
zikv
mosquito
mammalian
cell
line
howev
found
xrrna
mutant
produc
attenu
infect
phenotyp
use
infect
wellestablish
vivo
mous
model
anim
studi
perform
follow
guidelin
protocol
approv
institut
anim
care
use
committe
univers
colorado
anschutz
medic
campu
joseph
timpona
biofronti
institut
univers
colorado
boulder
boulder
co
usa
discuss
work
examin
potenti
role
pathogen
drive
evolut
host
complement
system
complement
system
compris
suit
circul
immun
protein
detect
destroy
pathogen
consequ
complement
protein
target
mani
evad
complementmedi
degrad
coopt
promot
infect
analyz
annot
complement
gene
pattern
posit
select
simian
primat
reveal
half
complement
gene
contain
rapidli
evolv
codon
uncov
potenti
hostpathogen
interfac
drive
rapid
evolut
assess
cocryst
structur
complement
protein
complex
viru
protein
use
cocryst
structur
echo
six
viru
capsid
cellular
attach
receptor
decay
acceler
factor
daf
found
key
amino
acid
facilit
interact
rapidli
evolv
primat
echovirus
may
drive
rapid
evolut
daf
primat
daf
turn
may
serv
speci
barrier
echoviru
spillov
event
human
anim
studi
perform
codi
warren
biofronti
institut
depart
molecular
cellular
development
biolog
univers
colorado
boulder
boulder
co
usa
present
work
select
use
primat
receptor
individu
chronic
infect
harbor
complex
viral
popul
within
bloodstream
new
infect
establish
one
virion
within
complex
viral
swarm
import
goal
character
biolog
properti
virion
seed
exist
earli
new
human
infect
potenti
virus
prophylact
vaccin
would
need
elicit
protect
includ
understand
envelop
env
protein
virion
interact
cell
receptor
support
attach
entri
target
cell
examin
earli
isol
abil
infect
cell
via
receptor
differ
primat
speci
found
primari
isol
blood
includ
earli
isol
highli
select
enter
cell
primat
receptor
ortholog
other
show
weak
bind
affin
bloodderiv
isol
make
sensit
small
sequenc
differ
one
primat
speci
next
sinc
weak
bind
nearli
univers
properti
circul
bloodstream
must
select
import
properti
biolog
bodi
identifi
six
primat
speci
encod
receptor
fulli
support
entri
earli
isol
despit
weak
bind
affin
find
help
inform
longstand
effort
model
transmiss
earli
diseas
primat
human
anim
studi
perform
joseph
westrich
colorado
state
univers
fort
collin
co
usa
present
work
examin
effect
matern
immun
respons
zikv
fetal
develop
advers
fetal
outcom
occur
roughli
live
due
prevent
environment
factor
includ
infect
addit
detriment
effect
pathogen
matern
immun
respons
pathogen
inadvert
contribut
fetal
outcom
immun
respons
interfac
shown
detriment
develop
fetu
peripher
matern
fetal
viral
infect
impact
immunolog
environ
interfac
remain
poorli
understood
understand
antivir
immun
respons
insult
effect
fetal
develop
establish
model
matern
antivir
respons
guinea
pig
mice
anim
mid
gestat
expos
either
zika
viru
zikv
poli
c
mimic
fetal
peripher
infect
respect
zikv
shown
cross
placent
barrier
neg
affect
fetal
develop
clinic
subclin
infect
altern
poli
c
noninfecti
viral
analogu
use
invok
peripher
antivir
immun
respons
evalu
immunolog
landscap
interfac
effect
growth
factor
known
alter
advers
fetal
develop
project
aim
understand
immun
growth
factor
lead
advers
fetal
develop
instig
antivir
immun
respons
prevent
viral
infect
pregnanc
impract
find
would
allow
greater
understand
impact
fetal
health
develop
therapeut
intervent
may
lessen
impact
infect
anim
studi
perform
follow
guidelin
protocol
approv
institut
anim
care
use
committe
colorado
state
univers
sabra
l
klein
john
hopkin
bloomberg
school
public
health
baltimor
md
usa
present
data
effect
biolog
sex
adapt
immun
respons
effect
may
impact
vaccin
efficaci
test
whether
greater
antibodi
femal
suffici
protect
influenza
male
femal
immun
inactiv
vaccin
induc
predominantli
antibodymedi
immun
follow
vaccin
femal
greater
antibodi
respons
protect
challeng
drift
variant
viru
male
antibodi
deriv
vaccin
femal
better
protect
male
femal
antibodi
male
protect
associ
increas
antibodi
specif
avid
viru
express
greater
b
cell
vaccin
femal
male
associ
reduc
dna
methyl
promot
region
higher
neutral
antibodi
class
switch
recombin
antibodi
avid
femal
delet
reduc
sex
differ
vaccineinduc
antibodi
respons
protect
follow
challeng
greater
impact
respons
femal
male
sex
differ
vaccin
efficaci
diminish
age
mice
determin
role
sex
steroid
vaccineinduc
immun
respons
adult
mice
gonadectom
hormon
estradiol
femal
testosteron
male
replac
subset
anim
vaccin
vaccineinduc
antibodi
respons
increas
femal
estradiol
decreas
male
testosteron
benefit
elev
estradiol
antibodi
respons
protect
influenza
femal
diminish
age
mice
human
taken
togeth
sex
steroid
xlink
gene
affect
antibodi
product
result
sexspecif
differ
efficaci
vaccin
influenza
work
support
nihniaid
center
excel
influenza
research
surveil
contract
hh
nihorwhnia
special
center
research
excel
sex
differ
anim
studi
perform
follow
guidelin
protocol
approv
institut
anim
care
use
committe
john
hopkin
bloomberg
school
public
health
sara
r
privatt
nebraska
center
virolog
school
biolog
scienc
univers
nebraska
lincoln
ne
usa
discuss
longitudin
quantif
adenoviru
neutral
respons
zambian
pair
order
determin
efficaci
adenoviru
vaccin
strategi
vaccin
offer
costeffect
approach
limit
infecti
neoplast
diseas
reduc
qualiti
life
subsaharan
africa
ssa
unclear
vaccin
vector
would
implement
set
age
appli
maxim
efficaci
adenovirus
ad
adbas
vector
demonstr
induc
effect
humor
cellular
immun
respons
anim
model
human
howev
immun
associ
ad
infect
lifelong
exist
debat
whether
preexist
immun
might
decreas
efficaci
ad
vector
vaccin
begin
develop
vaccin
strategi
ssa
quantifi
neutral
antibodi
nab
adult
women
infant
first
defin
decay
kinet
transfer
matern
nab
infant
well
initi
de
novo
ad
respons
find
demonstr
zambian
adult
robust
nab
respons
exist
ad
test
effici
transfer
newborn
neither
infect
statu
mother
antiretrovir
therapi
art
treatment
signific
impact
matern
ad
nab
respons
transfer
infant
matern
ad
nab
decay
infant
nadir
month
age
seven
ad
type
could
function
vaccin
vector
definit
window
opportun
provid
import
foundat
data
ration
design
implement
ad
vector
set
studi
use
human
subject
tissu
sampl
either
approv
deem
nonhuman
subject
research
institut
review
board
univers
nebraskalincoln
univers
teach
hospit
lusaka
zambia
sydney
townsend
along
catherin
chundaliyoka
john
west
charl
wood
nebraska
center
virolog
univers
nebraskalincoln
lincoln
ne
usa
depart
pediatr
child
health
univers
teach
hospit
lusaka
zambia
detect
high
nnrti
resist
level
infect
zambian
mother
infant
option
b
implement
subsaharan
africa
effort
prevent
mother
child
transmiss
pmtct
option
b
involv
treat
pregnant
lactat
women
combin
antiretrovir
therapi
art
life
give
infant
prophylaxi
immedi
postdeliveri
option
b
success
reduc
mtct
rate
lack
resourc
zambia
left
mani
mothersinf
suscept
drug
resist
drug
resist
mutat
drm
develop
quickli
select
pressur
may
linger
long
period
time
thu
import
elucid
relationship
art
resist
mother
infect
infant
investig
drug
resist
variant
transmit
mother
infant
quantifi
preval
drug
resist
postopt
b
implement
dri
blood
spot
dbss
collect
pair
routin
screen
lusaka
zambia
dna
extract
hiv
pol
amplifi
sequenc
submit
stanford
hivdb
http
hivdbstanfordedu
fortynin
percent
sampl
least
one
drm
resist
least
two
art
infant
greater
amount
drm
lead
higher
magnitud
resist
preval
nnrti
resist
significantli
higher
art
class
studi
reduc
preval
drm
infant
need
emphas
necessari
chang
proteas
inhibitor
pi
base
integras
inhibitor
ini
base
regimen
treatment
infect
infant
mother
zambia
studi
use
human
subject
tissu
sampl
either
approv
deem
nonhuman
subject
research
institut
review
board
univers
nebraskalincoln
sue
vandewoud
depart
microbiolog
immunolog
patholog
colorado
state
univers
fort
collin
co
usa
present
data
gener
laboratori
colleagu
univers
minnesota
wildlif
agenc
florida
colorado
california
relat
emerg
viral
outbreak
result
host
switch
freerang
puma
concolor
puma
infect
contactdepend
agent
origin
domest
cat
bobcat
presum
via
interact
overwhelmingli
favor
surviv
puma
individu
crossspeci
transmiss
event
infer
felin
retrovir
genom
data
includ
spillov
felin
immunodefici
viru
infect
bobcat
fivlru
puma
felin
leukemia
viru
felv
felin
foami
viru
ffv
domest
cat
puma
interestingli
infect
differ
outcom
new
host
fivlru
high
fit
bobcat
replic
poorli
posit
select
puma
felin
leukemia
viru
domest
cat
readili
caus
diseas
puma
domest
cat
felv
replic
faster
puma
versu
domest
cat
cell
ffv
spread
effici
puma
puma
limit
host
restrict
barrier
onward
transmiss
seri
complex
paramet
rang
scale
puma
habitat
use
intrins
molecular
interact
viru
new
host
determin
risk
outcom
crossspeci
infect
anim
studi
perform
follow
guidelin
protocol
approv
colorado
state
univers
institut
anim
care
use
committe
shidizja
altamirano
depart
microbiolog
immunolog
patholog
colorado
state
univers
fort
collin
co
usa
discuss
paratransgen
deliveri
dsrna
stimul
mosquito
antivir
rnai
respons
recombin
sindbi
viru
contain
enhanc
green
fluoresc
protein
sindbisegfp
yellow
fever
mosquito
aed
aegypti
one
preval
vector
human
diseas
known
transmit
addit
yellow
fever
chikungunya
dengu
zika
virus
arbovir
diseas
affect
health
peopl
inhabit
tropic
subtrop
region
grow
contributor
global
morbid
mortal
effort
manag
mosquito
popul
spread
pathogen
vector
great
import
improv
health
human
worldwid
project
transgen
bacteri
symbiont
develop
goal
introduc
dsegfp
mosquito
midgut
subsequ
interrupt
arboviru
infect
recombin
sindbisegfp
togavirida
viru
system
dsrna
expect
serv
trigger
mosquito
rna
interfer
antivir
immun
pathway
hypothesi
insid
mosquito
midgut
dsegfp
nt
process
mosquito
rnai
immun
pathway
project
develop
quantit
assay
detect
srna
mosquito
midgut
preval
bacteriatranscrib
mosquitoprocess
srna
determin
use
qpcr
standard
number
coloni
form
unit
luria
broth
agar
plate
project
help
us
identifi
specif
symbiont
strain
colon
mosquito
midgut
effici
releas
dsegfp
process
srna
rnai
trigger
addit
research
test
method
could
provid
vital
inform
optim
paratransgen
bacteria
strain
human
anim
studi
perform
laura
ashton
along
jasmin
mccoy
garin
wilson
mariah
jordan
sandra
quackenbush
ami
macneil
depart
microbiolog
immunolog
patholog
colorado
state
univers
fort
collin
co
usa
show
myxvorfc
myxoma
viru
express
proapoptot
protein
induc
oncolysi
apoptosi
attenu
rabbit
oncolyt
virotherapi
use
myxoma
viru
myxv
shown
efficaci
cancer
model
howev
myxv
replic
within
tumor
shortliv
success
treatment
requir
frequent
inject
hypothes
engin
recombin
myxv
promot
apoptosi
myxvorfc
could
improv
efficaci
myxv
signific
increas
p
cell
death
due
apoptosi
observ
myxvorfc
compar
myxvinfect
cell
h
postinocul
hpi
rabbit
kidney
epitheli
canin
osteosarcoma
canin
soft
tissu
sarcoma
cell
activ
cytochrom
c
oxidas
significantli
p
increas
myxvorfc
compar
myxv
mockinfect
cell
hpi
assess
safeti
myxvorfc
vivo
new
zealand
white
rabbit
challeng
myxvorfc
wildtyp
myxv
rabbit
infect
myxvorfc
surviv
longer
p
delay
onset
clinic
sign
compar
rabbit
infect
myxv
futur
studi
determin
myxvorfc
effect
oncolyt
viru
myxv
fund
colleg
veterinari
medicin
biomed
scienc
anim
health
innov
fund
evalu
pathogenesi
myxvorfc
rabbit
anim
studi
perform
follow
guidelin
protocol
approv
institut
anim
care
use
committe
colorado
state
univers
nathaniel
denker
prion
research
center
depart
microbiolog
immunolog
patholog
colorado
state
univers
fort
collin
co
usa
present
comparison
realtim
convers
immunohistochemistri
techniqu
detect
chronic
wast
diseas
whitetail
deer
chronic
wast
diseas
cwd
continu
expand
across
north
america
canada
recent
discov
scandinavia
exact
mechan
cwd
transmiss
yet
elucid
earli
diagnosi
infect
anim
remain
prioriti
curtail
spread
immunohistochemistri
ihc
remain
gold
standard
diagnos
cwd
realtim
quak
induc
convers
rtquic
detect
substanti
lower
concentr
prion
sought
compar
sensit
rtquic
ihc
seri
longitudin
tonsil
rectoan
mucos
lymphoid
tissu
ramalt
biopsi
cwd
inocul
whitetail
deer
throughout
diseas
progress
rtquic
detect
seed
activ
tonsil
biopsi
averag
month
month
earlier
ihc
detect
averag
month
month
earlier
ramalt
biopsi
detect
concurr
method
remain
biopsi
ihc
posit
result
never
preced
posit
rtquic
result
addit
biopsi
sampl
alreadi
posit
rtquic
ihc
previou
collect
rtquic
detect
seed
activ
followup
biopsi
lymphoid
follicl
present
confirm
ihc
biopsi
cwd
deer
neg
throughout
studi
overal
result
demonstr
rtquic
detect
cwd
posit
tonsil
ramalt
biopsi
approxim
month
prior
ihc
moreov
seed
activ
detect
even
lymphoid
follicl
present
permit
meaning
ihc
analysi
data
indic
rtquic
sensit
ihc
detect
cwd
infect
could
use
implement
manag
strategi
anim
studi
perform
follow
guidelin
protocol
approv
institut
anim
care
use
committe
colorado
state
univers
caitlyn
kraft
prion
research
center
depart
microbiolog
immunolog
patholog
colleg
veterinari
medicin
biomed
scienc
colorado
state
univers
fort
collin
co
usa
present
research
detect
chronic
wast
diseas
prion
nasal
swab
collect
cwdinocul
deer
chronic
wast
diseas
cwd
emerg
transmiss
spongiform
encephalopathi
cervid
identifi
north
america
south
korea
scandinavia
exact
mechan
cwd
transmiss
remain
unknown
thu
effort
identifi
pathway
prion
shed
transmiss
remain
high
prioriti
previou
studi
shown
nasal
olfactori
epithelium
contain
cwd
seed
activ
yet
tempor
profil
prion
shed
nasal
secret
identifi
studi
character
cwd
pathogenesi
use
longitudin
nasal
swab
sampl
twenti
cwdinocul
deer
ironoxid
magnet
extract
coupl
realtim
quak
induc
convers
iomertqu
protocol
correl
assay
find
longitudin
tonsil
biopsi
termin
tissu
sampl
deer
assay
immunohistochemistri
rtquic
result
demonstr
prion
shed
nasal
secret
deer
earli
two
month
first
tonsil
biopsi
posit
mean
month
rang
month
detect
persist
prion
shed
nasal
fluid
occur
deer
prion
seed
activ
frontal
cortex
olfactori
bulb
region
brain
demonstr
deer
suggest
brain
involv
preced
nasal
shed
conclud
cwdinfect
deer
shed
prion
nasal
secret
throughout
mid
late
stage
pathogenesi
direct
nasal
contact
common
social
interact
like
nasal
fluid
play
signific
role
horizont
transmiss
moreov
nasal
swab
may
also
constitut
access
sampl
antemortem
diagnosi
use
rtquic
assay
anim
studi
perform
follow
guidelin
protocol
approv
institut
anim
care
use
committe
colorado
state
univers
w
ian
lipkin
center
infect
immun
mailman
school
public
health
columbia
univers
nyc
ny
usa
gave
postprandi
tour
review
promis
new
tool
microbi
discoveri
diagnost
opportun
younger
member
audienc
expand
field
microbiolog
chronic
well
acut
diseas
pitfal
sensit
molecular
method
pathogen
discoveri
way
microbiolog
help
us
understand
disrupt
social
fabric
pose
pandem
threat
least
real
ebola
influenza
human
anim
studi
perform
ami
macneil
along
laura
ashton
depart
microbiolog
immunolog
patholog
colorado
state
univers
fort
collin
co
usa
demonstr
myxoma
viru
myxv
replic
neoplast
canin
cell
affect
type
interferon
ifn
better
understand
immunolog
respons
canin
cell
myxv
need
improv
effect
myxoma
viru
myxv
oncolyt
therapi
dog
cytokin
respons
myxv
inocul
cancer
cell
st
osa
permiss
myxv
infect
compar
nonpermiss
canin
fibroblast
use
qpcr
cytokin
mrna
express
myxvinfect
cell
calcul
rel
mockinfect
cell
h
postinocul
hpi
transcript
significantli
p
lower
st
hpi
osa
hpi
upregul
hpi
osa
hpi
st
chang
transcript
inconsist
cancer
cell
previou
work
human
murin
cancer
cell
indic
speciesspecif
combin
cytokin
block
myxv
infect
therefor
treat
st
osa
cell
alon
combin
treatment
cytotox
st
osa
cell
signific
p
reduct
viral
replic
observ
canin
cancer
cell
treat
alon
combin
propos
regul
type
ifn
respons
could
allow
target
adjust
myxv
replic
spontan
tumor
dog
fund
colorado
state
univers
clinic
patholog
research
develop
fund
anim
human
studi
perform
nathan
mankovich
advis
michael
kirbi
depart
mathemat
colorado
state
univers
fort
collin
co
usa
present
mathemat
techniqu
accur
detect
whether
human
subject
shed
influenza
viru
use
small
number
gene
express
level
method
consist
multipl
networkbas
featur
select
algorithm
detect
discrimin
biomark
method
begin
realiz
microarray
data
set
network
use
correl
partial
correl
heat
kernel
random
edg
gener
method
small
set
gene
select
network
via
spectrum
graph
laplacian
adjac
supraadjac
matric
human
anim
studi
perform
method
use
gse
dataset
avail
ncbi
websit
erin
mcnulti
colorado
state
univers
fort
collin
co
usa
discuss
prion
highli
resist
inactiv
convent
steril
process
center
diseas
control
cdc
recommend
decontamin
infecti
agent
associ
prion
includ
exposur
part
per
million
ppm
sodium
hypochlorit
min
high
pressureautoclav
h
high
pressurehigh
temperatur
autoclav
typic
use
inactiv
prion
present
plastic
person
protect
equip
within
small
quantiti
tissueshomogen
routin
use
laboratori
personnel
laboratori
bench
equip
instrument
routin
expos
ppm
sodium
hypochlorit
due
corros
natur
high
sodium
hypochlorit
concentr
investig
search
effect
mean
inactiv
prion
result
less
damag
laboratori
set
end
acet
acid
sodium
lauryl
sulfat
acet
sd
incorpor
prion
laboratori
clean
regimen
studi
explor
efficaci
shortterm
exposur
ppm
hypochlorit
acet
sd
inactiv
prion
infect
laboratori
set
use
prion
amplif
mous
bioassay
demonstr
laboratori
clean
regimen
includ
shortterm
exposur
ppm
hypochlorit
result
steril
inactiv
cwd
prion
infect
acet
sd
decreas
cwd
burden
studi
provid
find
guid
develop
prion
laboratori
clean
procedur
anim
studi
perform
follow
guidelin
protocol
approv
institut
anim
care
use
committe
colorado
state
univers
ami
nall
colorado
state
univers
fort
collin
co
usa
discuss
detect
hematogen
prion
chronic
wast
diseas
studi
blood
contain
infecti
agent
associ
prion
diseas
affect
sever
mammalian
speci
includ
human
creutzfeldtjakob
diseas
cjd
cervid
chronic
wast
diseas
cwd
sheep
scrapi
cattl
bovin
spongiform
encephalopathi
bse
confirm
suffici
prion
agent
present
blood
symptomat
asymptomat
carrier
initi
amyloid
templat
accumul
process
result
fatal
neurodegen
diseas
yet
date
abil
detect
bloodborn
prion
vitro
method
remain
difficult
work
focus
refin
prion
amplif
method
rtquic
pmca
util
bank
blood
sampl
collect
cwd
studi
nativ
whitetail
deer
host
examin
hematogen
prion
load
blood
collect
deer
orallyinocul
variou
amount
sourc
cwd
demonstr
prion
seed
activ
buffi
coat
cell
harvest
subclin
clinic
cwdposit
deer
abil
detect
prion
buffi
coat
blood
cell
harvest
deer
oral
dose
ng
cwdposit
brain
saliva
detect
prion
buffi
coat
cell
harvest
subclin
cwdposit
deer
find
permit
assess
role
hematogen
prion
play
pathogenesi
cwd
provid
tool
assess
prion
diseas
mammalian
speci
anim
studi
perform
follow
guidelin
protocol
approv
institut
anim
care
use
committe
colorado
state
univers
trey
k
snell
depart
microbiolog
immunolog
patholog
colorado
state
univers
fort
collin
co
usa
present
work
develop
immunofluoresc
immunoprecipit
assay
character
paratransgen
deliveri
dsrna
mosquito
midgut
aed
aegypti
mosquito
play
major
role
arboviru
transmiss
vector
project
transgen
bacteri
symbiont
develop
purpos
introduc
dsegfp
mosquito
midgut
subsequ
interrupt
arboviru
infect
use
recombin
sindbisegfp
togavirida
viru
system
expect
bacterialdeliv
dsrna
serv
trigger
mosquito
rna
interfer
rnai
antivir
pathway
reduc
viral
replic
confoc
microscopi
use
demonstr
dsegfp
deliv
mosquito
midgut
addit
immunoprecipit
rnainduc
silenc
complex
risc
protein
perform
show
dsrna
process
srna
risc
differ
strain
escherichia
coli
e
coli
symbiont
transform
express
dsgfp
andor
bacteria
introduc
adult
mosquito
use
sucros
feed
solut
four
day
later
midgut
harvest
confoc
microscopi
second
experi
complex
immunoprecipit
mosquito
homogen
subsequ
rna
extract
use
isol
srna
rtqpcr
srna
perform
investig
help
us
build
support
hypothesi
paratransgen
deliveri
rnai
trigger
produc
function
antivir
srna
mosquito
reduc
arbovir
load
human
anim
studi
perform
